CoChat
Sign Up
Cited by 41Pituitary Gland Disorders and TreatmentsGrowth Hormone and Insulin-like Growth FactorsHyperglycemia and glycemic control in critically ill and hospitalized patients

Italian Society for the Study of Diabetes (SID)/Italian Endocrinological Society (SIE) guidelines on the treatment of hyperglycemia in Cushing’s syndrome and acromegaly

Baroni, M. G., Giorgino, F., Pezzino, V., Scaroni, C., Avogaro, A.·2016·Journal of Endocrinological Investigation
DOI 10.1007/s40618-015-0404-6
Open this paper in CoChat — free account

Abstract

Hyperglycemia is a common feature associated with states of increased growth hormone secretion and glucocorticoid levels. The purpose of these guidelines is to assist clinicians and other health care providers to take evidence-based therapeutic decisions for the treatment of hyperglycemia in patients with growth hormone and corticosteroid excess. Both the SID and SIE appointed members to represent each society and to collaborate in Guidelines writing. Members were chosen for their specific knowledge in the field. Each member agreed to produce-and regularly update-conflicts of interest. The authors of these guidelines prepared their contributions following the recommendations for the development of Guidelines, using the standard classes of recommendation shown below. All members of the writing committee provided editing and systematic review of each part of the manuscript, and discussed the grading of evidence. Consensus was guided by a systematic review of all available trials and by interactive discussions.

Integrity signals

Registry

Crossref · 10.1007/s40618-015-0404-6

Cites

184 of 184 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Controlling hypercortisolism is the first step toward improving glucose metabolism in endogenous Cushing syndrome, but different treatments may affect diabetes outcome regardless of how well cortisol excess is corrected.

    “Controlling hypercortisolism is the first step toward improving glucose metabolism in patients with endogenous CS, but different treatments for hypercortisolism may affect the outcome of diabetes, regardless of how well cortisol excess is corrected (, , , , , , ).”

    From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [264]

  • No studies have specifically investigated the role of antidiabetic therapy in treating hyperglycemia in patients with endogenous Cushing syndrome.

    “Although GCs are well known to induce DM, no studies have specifically investigated the role of antidiabetic therapy in the treatment of hyperglycemia in patients with endogenous CS, and few studies have reported the effects of some antidiabetic agents in exogenous GC-induced hyperglycemia.”

    From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [264]

  • Few studies have reported the effects of some antidiabetic agents in exogenous glucocorticoid-induced hyperglycemia.

    “Although GCs are well known to induce DM, no studies have specifically investigated the role of antidiabetic therapy in the treatment of hyperglycemia in patients with endogenous CS, and few studies have reported the effects of some antidiabetic agents in exogenous GC-induced hyperglycemia.”

    From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [264]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Related

Authors
Baroni, M. G., Giorgino, F., Pezzino, V., Scaroni, C., & Avogaro, A.
Affiliations
  • Sapienza University of Rome (IT)
  • University of Bari Aldo Moro (IT)
  • University of Catania (IT)
  • University of Padua (IT)
Corresponding author
Avogaro, A.
ORCID
Venue
Journal of Endocrinological Investigation
Publisher
Springer Science and Business Media LLC
Published
2015-12-30
Volume
39
Issue
2
Pages
235-255
ISSN
  • 0391-4097 (ISSN-L)
  • 1720-8386
DOI
10.1007/s40618-015-0404-6
OpenAlex
W2277055097
Cited by
41
References
184
Citations by year
2026: 2 · 2025: 1 · 2024: 1 · 2023: 8 · 2022: 2 · 2021: 3 · 2020: 6 · 2019: 3 · 2018: 5 · 2017: 5 · 2016: 4 · 2015: 1
FWCI
4.35
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Journal of Endocrinological Investigation (publishedVersion)
  • PubMed (publishedVersion)
  • IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
  • CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro) (submittedVersion)
  • Archivio Istituzionale della Ricerca - Università degli Studi dell Aquila (submittedVersion)
  • Padua Research Archive (University of Padova) (submittedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
Keywords
hyperglycemia, Cushing's syndrome, acromegaly, growth hormone excess, glucocorticoid excess, diabetes treatment, corticosteroid excess, evidence-based care
MeSH terms
Acromegaly, Combined Modality Therapy, Cushing Syndrome, Diabetes Mellitus, Endocrinology, Glucocorticoids, Humans, Hyperglycemia, Italy, Societies, Scientific, Evidence-Based Medicine, Human Growth Hormone, Consensus, Precision Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review